Rockwell Medical (RMTI) Receivables (2010 - 2026)

Rockwell Medical's Receivables history runs 17 years deep, the most recent figure standing at $8.8 million for Q1 2026.

• Quarterly Receivables fell 8.74% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (down 8.74% YoY) and the FY2025 annual result came in at $8.1 million, down 1.79% from the prior year.
• Receivables was $8.8 million for Q1 2026 at Rockwell Medical, up from $8.1 million in the prior quarter.
• Across five years, Receivables topped out at $16.2 million in Q2 2022 and bottomed at $5.4 million in Q2 2023.
• A 5-year average of $10.1 million and a median of $9.4 million in 2023 frame the typical range for Receivables.
• Annual changes were most pronounced in 2023 — Receivables slumped 66.56% — and 2024, when it surged 100.33%.
• Rockwell Medical's Receivables stood at $12.5 million in 2022, then decreased by 12.92% to $10.9 million in 2023, then retreated by 23.94% to $8.3 million in 2024, then dropped by 1.79% to $8.1 million in 2025, then advanced by 8.38% to $8.8 million in 2026.
• Business Quant data shows RMTI's Receivables at $8.8 million in Q1 2026, $8.1 million in Q4 2025, and $8.3 million in Q3 2025.